A Study to Investigate Efficacy and Safety of Duvakitug in Adult Participants With Moderate to Severe Hidradenitis Suppurativa | MicrobiomeTrials← Back to trialsNCT07812116
A Study to Investigate Efficacy and Safety of Duvakitug in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-10-13Est. Completion: 2028-06-16
Enrollment target: 156 participants Other microbiome trials you might be interested in
VitiligoAtopic DermatitisAlopecia AreataHidradenitis Suppurativa (HS)
TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatol…
New York, United StatesEst. completion Aug 3, 2041
Hidradenitis Suppurativa (HS)
This study will build on data from mice and humans implicating TRPV1 nociceptors in the pathogenesis of the type-17 chro…
Worcester, United StatesEst. completion Sep 2028